3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Solid Tumors
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Hodgkin Disease
1
Burkitt Lymphoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Specimen Handling
7
Biopsy
7
Magnetic Resonance Spectroscopy
6
duvelisib
3
X-Rays
3
sodium-iodide symporter
2
cemiplimab
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immunoglobulin G
2
Etoposide
2
Disulfides
2
Cyclophosphamide
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
talimogene laherparepvec
1
ruxolitinib
1
pembrolizumab
1
carmustine, poliferprosan 20 drug combination
1
belinostat
1
Whole-Body Irradiation
1
Vincristine
1
Stem Cell Transplantation
1
Standard of Care
1
Spinal Puncture
1
Prednisone
1
Practice Guidelines as Topic
1
Pharmacogenomic Variants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
pegylated granulocyte colony-stimulating factor
×
30 days
×
Clear all
No trials found.